VEGFA and diabetic macular edema: Although the number of injections required was similar between groups, the better response in the low-dose group highlights the need for further investigation into the dose-dependent effects of statins in the management of diabetic macular edema.<h4>Conclusions</h4>Low-dose atorvastatin (10-20 mg) as an adjunct to anti-VEGF therapy resulted in better functional and anatomical outcomes in diabetic patients with CSME compared to high-dose atorvastatin.